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A B S T R A C T   
Bryophyllum constitutes a subgenus within the genus Kalanchoe that contains several plant species used in 
traditional medicine worldwide for the treatment of several diseases. However, little is known about the phy-
toconstituents of Bryophyllum spp. and previous reports have pointed at their low in Planta concentrations of 
bioactive compounds. In this work, we take advantage of plant in vitro culture for the study of the phenolic 
compounds found in the aerial parts of Bryophyllum spp. and their associated bioactivities. Our results show that 
the induction of nutritional stress leads to an improved accumulation of phenolic compounds, mainly flavonols 
and anthocyanins, represented by myricetin and malvidin glycosides, respectively. This effect is mainly found for 
B. × houghtonii, whose hydroethanolic extracts promoted the highest antioxidant, cytotoxic and anti- 
inflammatory activities. In the case of cytotoxic activity, Bryophyllum extracts showed an enhanced activity 
against the MCF-7 human breast carcinoma cell line. Meanwhile, extracts from B. daigremontianum promoted a 
wide range of effectiveness against different bacterial and fungal strains. This study is committed to shed light 
about the phytochemical potential associated to this unexplored subgenus, with the aim of considering Bryo-
phyllum spp. as a valuable source of bioactive compounds for their exploitation in food, cosmetic and pharma-
ceutical industries.   
1. INTRODUCTION 
The subgenus Bryophyllum (genus Kalanchoe, Crassulaceae) contains 
more than 25 species widely used for ornamental and medicinal pur-
poses (Descoings, 2006). The medicinal properties attributed to Bryo-
phyllum spp. have been reported by their use as part of plant-derived 
formulations in the traditional medicine across Africa, Asia and South 
America (Fürer et al., 2016; García-Pérez et al., 2019). Hence, Bryo-
phyllum formulations have been used in the traditional medicine for the 
treatment of several ailments including infections, diabetes, rheumatism 
and inflammatory and neoplastic diseases across Africa, Asia and South 
America (Kolodziejczyk-Czepas and Stochmal, 2017; Quazi Majaz et al., 
2011). Such medicinal properties are a consequence of the vast number 
of secondary metabolites found in several Bryophyllum species, that can 
be classified into different families, such as phenolic compounds, 
bufadienolides and isoprenoids, among others (Milad, 2014). 
Nevertheless, the phytochemical studies of these species have 
focused on the identification and quantification of bufadienolides and 
their associated cytotoxic bioactivity (Fürer et al., 2016; Kolodziejc-
zyk-Czepas and Stochmal, 2017; Stefanowicz-Hajduk et al., 2020a). In 
contrast, the analysis of phenolic compounds is scarce and only limited 
information is available about this family of phytoconstituents on 
Bryophyllum spp. (Bogucka-Kocka et al., 2016), which have been widely 
reported as antioxidant, anti-inflammatory, anti-microbial and cytotoxic 
agents (Oroian and Escriche, 2015). 
Moreover, phytochemical studies conducted on Bryophyllum spp. 
have been performed using raw plant materials from conventional 
breeding. Consequently, an excessive amount of plant biomass was 
needed, as very low yields were achieved (de Paiva et al., 2008d; Mahata 
et al., 2012). As a solution, the establishment of Bryophyllum plant in 
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vitro culture emerges as a powerful tool to consider their potential as a 
valuable source of bioactive compounds (García-Pérez et al., 2019a, 
2020a, 2020b, 2020c). Plant tissue culture technology offers some ad-
vantages to accomplish this goal, such as the independence of geo-
climatic conditions, the absence of potential pollutants (avoiding the use 
of pesticides and other chemicals), and the capability to get a stable 
production of true-to-type plant-derived products (Dias et al., 2016). 
Additionally, plant tissue culture enables the modulation of secondary 
metabolite biosynthesis, mediated by the induction of plant stress 
throughout a phenomenon known as elicitation (Moon et al., 2020). 
Elicitation has been implemented as an effective strategy for enhancing 
secondary metabolite activity, enabling their production at industrial 
level, as reported for a wide range of plant species (Narayani and Sri-
vastava, 2017). Furthermore, the success of Bryophyllum in vitro culture 
is supported by the exceptional asexual reproduction developed along 
the leaf margins of mature plants, which involves the generation 
fully-developed epiphyllous plantlets (Garcês and Sinha, 2009; Garcês 
et al., 2014), as already demonstrated (García-Pérez et al., 2020d). 
In the present work, the identification and quantification of phenolic 
compounds from three in vitro-cultured Bryophyllum species was per-
formed, providing valuable information about the heterogeneity of these 
compounds. In addition, the induction of nutritional stress by reducing 
the concentration of macronutrients on the culture media as a potential 
strategy to enhance the production of phenolic compounds (Gar-
cía-Pérez et al., 2020b), was evaluated. Finally, different biological ac-
tivities, including antioxidant, cytotoxic, anti-inflammatory and 
antimicrobial were assessed, in order to determine the health-enhancing 
properties associated to Bryophyllum cultured in vitro. The knowledge 
provided by this work will aid considering the unexploited potential of 
these medicinal plants from the Bryophyllum subgenus as valuable 
sources of bioactive compounds for industrial purposes. 
2. MATERIALS AND METHODS 
2.1. Plant material and culture conditions 
Three different species belonging to Bryophyllum subgenus were used 
in this work, namely: Bryophyllum daigremontianum Raym. – Hamet et 
Perr. (syn. Kalanchoe daigremontiana), Bryophyllum × houghtonii D.B. 
Ward (B. daigremontianum × tubiflorum, syn. Kalanchoe daigremontiana ×
tubiflora) and Bryophyllum tubiflorum Harv. (syn. Kalanchoe tubiflora). 
One-year-old plants were harvested in a local greenhouse (Vigo, Spain) 
and epiphyllous plantlets were detached from mother plants. Then, 
plantlets were disinfected and subjected to in vitro culture conditions as 
previously reported (García-Pérez et al., 2019a). Briefly, after disinfec-
tion, plantlets were transferred in pairs to glass culture vessels con-
taining 25 mL of previously autoclaved full-strength MS medium 
(Murashige and Skoog, 1962) or half-strength macronutrient MS me-
dium (1/2MS; García-Pérez et al., 2020b). The 1/2MS formulation was 
already applied to Bryophyllum in vitro culture for the induction of 
nutritional stress, leading to the production of phenolic compounds 
(García-Pérez et al., 2020b). Cultures were then randomly placed in 
growth chambers under a photoperiod of 16 h light and 8 h dark at 25 ±
1 ◦C for 12 weeks. Plants were subcultured every 12 weeks by trans-
ferring newly-formed plantlets to fresh culture medium, as previously 
established (García-Pérez et al., 2020b). After each subculture, aerial 
parts from 12-week-old in vitro-grown plants were excised and imme-
diately frozen at − 20 ◦C until use. Aerial parts from three consecutive 
subcultures were merged prior sample extraction, as described in the 
next section. 
2.2. Sample extraction 
Once frozen, samples were lyophilized, powder homogenized and 
subjected to solid-liquid extraction, using 1.0 g of lyophilized materials 
and 30 mL of 80% (v/v) EtOH for 1 h at 150 rpm at room temperature. 
Samples were extracted twice and supernatants were combined to get 
the raw extract. Extracts were then filtered throughout Whatmann paper 
no. 4 and concentrated under reduced pressure in a rotary evaporator. 
The aqueous phase was removed by lyophilization and the solid dry 
extract was resuspended with 20% (v/v) EtOH at a final concentration of 
5 mg mL-1. Hydroethanolic extracts were filtered using 0.22 μm 
disposable LC filter disks, prior to their chromatographic analysis. 
For the analysis of anthocyanins, the sample extraction procedure 
was performed under the same conditions but using acidified 80% (v/v) 
EtOH with 1% (v/v) trifluoroacetic acid as solvent. 
2.3. Analysis of phenolic compounds 
The analysis of phenolic compounds was performed by HPLC-DAD- 
ESI/MSn (Dionex Ultimate 3000 UPLC, Thermo Scientific, San Jose, CA, 
USA), as previously reported by Bessada et al. (2016) for the 
non-anthocyanin phenolic compounds and by Gonçalves et al. (2017) 
for the anthocyanin compounds. The detection of phenolic compounds 
was achieved using diode-array detector programmed with the prefer-
ence wavelengths at 280, 330 and 370 nm for non-anthocyanin phenolic 
compounds, and 520 nm for anthocyanin compounds, also coupled to a 
Linear Ion Trap LTQ XL mass spectrometer (Thermo Finnigan, San Jose, 
CA, USA), working in negative (identification of non-anthocyanin 
phenolic compounds) and positive (identification of anthocyanin com-
pounds) mode and was equipped with an ESI source. 
Identification of phenolic compounds was achieved through their 
comparison to commercial standards, when available, in terms of their 
retention times and UV-Vis spectra. When standards were not available, 
tentative identification was offered, based on additional information 
from the literature. Quantitative analysis was developed using calibra-
tion curves obtained from the UV-Vis signal of available phenolic stan-
dards: naringenin (y = 18433x + 78903; R2 = 0.9998), apigenin-6-C- 
glucoside (y = 107025x + 61531; R2 = 0.9989), quercetin-3-O-rutino-
side (y = 13343x + 76751; R2 = 0.9998), myricetin (y = 23287x – 
581708; R2 = 0.9988), quercetin-3-O-glucoside (y = 34843x – 160173; 
R2 = 0.9998) and peonidin-3-O-glucoside (y = 151438x – (3 106); R2 =
0.9977). Results were expressed as mg g-1 of dry extract. 
2.4. Evaluation of in vitro biological activities 
2.4.1. Antioxidant activity 
In order to determine the antioxidant activity associated to Bryo-
phyllum extracts, two different in vitro assays were conducted, including 
the determination of extracts capacity on the inhibition of thiobarbituric 
acid reactive substances (TBARS) and oxidative hemolysis (OxHLIA), 
based on previous works (Lockowandt et al., 2019). In both cases, 
oxidizable subtracts were used: porcine brain cells for TBARS assay and 
sheep erythrocytes for OxHLIA assay (Δt = 60 min). Trolox was selected 
as positive control for both assays and results were expressed as IC50 
values, in μg mL-1. 
2.4.2. Cytotoxic and hepatotoxic activity 
Plant extracts at the concentration of 50-400 μg mL-1 (in water) were 
used for the determination of cytotoxic activity by the sulforhodamine B 
method (Guimarães et al., 2013) against different human tumor cell 
lines: NCI-H460 (non-small cell lung carcinoma), MCF-7 (breast 
adenocarcinoma), HeLa (cervical carcinoma) and HepG2 (hepatocellu-
lar carcinoma). The non-tumor PLP2 cell line (porcine liver primary 
cells) was used for the determination of hepatotoxicity. Elipticine was 
selected as the positive control, and the results were expressed as GI50 
values, in μg mL-1. 
2.4.3. Anti-inflammatory activity 
Plant extracts at the concentration of 0.125-0.4 mg mL-1 (in water) 
were tested for the determination of anti-inflammatory activity. Briefly, 
the stimulation of murine macrophages RAW 264.7 cell line (provided 
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by European Collection of Animal Cell Culture, ECACC, Salisbury, UK) 
by lipopolysaccharide (LPS), was measured by means of nitric oxide 
(NO) production by using the Griess Reagent System kit (Promega, WI, 
USA), as previously described (Souilem et al., 2017). Dexamethasone 
was used as positive control and the results were expressed as IC50 
values, in μg mL-1. 
2.4.4. Antimicrobial activity 
Plant extracts at the concentration of 0.1-20 mg mL-1 (in 30% 
ethanol) were tested for antibacterial and antifungal assays through the 
microdilution method (Heleno et al., 2013). All microorganisms were 
provided by the Institute for Biological Research “Sinisa Stanković” – 
National institute of Republic of Serbia, University of Belgrade, Serbia. 
For antibacterial analysis the next three Gram-positive strains: Bacillus 
cereus (food isolate), Listeria monocytogenes (NCTC7973) and Staphylo-
coccus aureus (ATCC 6538); and the next Gram-negative strains: 
Escherichia coli (ATCC 25922), Enterobacter cloacae (ATCC 35030) and 
Salmonella Typhimurium (ATCC13311) were used. For antifungal ac-
tivity, the selected Aspergillus strains: A. fumigatus (ATCC 1022), 
A. ochraceus (ATCC 12066) and A. niger (ATCC 6275); and Penicillium 
strains: P. ochrochloron (ATCC 9112), P. funiculosum (ATCC 36839) and 
P. verrucosum var. cyclopium (food isolate) were used. Streptomycin and 
ampicillin were used as a positive control for antibacterial assays, 
whereas ketoconazole and bifonazole were selected as positive control 
for the antifungal assays, while 30% ethanol was used as a negative 
control. The results were presented as minimum inhibitory concentra-
tion (MIC, required for microbial growth inhibition), bactericidal (MBC) 
and fungicidal concentrations (MFC), expressed in mg mL-1. 
Table 1 
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Statistical differences were assessed by one-way ANOVA, followed by Tukey’s HSD post hoc test (α = 0.05): lower-case letters indicate significant differences among 
treatments within the same species, whereas upper-case letters indicate significant differences among species within the same treatment. [M-H]- was used for non- 
anthocyanins phenolic compounds and [M]+ for anthocyanin compounds. Rt - retention time (min); λmax - maximum absorption wavelengths and their eventual 
shifts (sh); [M-H]- and [M]+ - mass spectral data; MS2 - fragment ions generated and their abundance (in brackets); nd – not detected; tr – trace amounts. Standard 
compounds used for quantification: 1Naringenin (y = 18433x + 78903, R2 = 0.9998, LOD = 0.17 μg/mL; LOQ = 0.81 μg/mL); 2Apigenin-6-C-glucoside (y = 197337x +
30036, R2 = 0.9997, LOD = 0.19 μg/mL; LOQ = 0.63 μg/mL); 3Quercetin-3-O-rutinoside (y = 13343x + 76751, R2 = 0.9998, LOD = 0.14 μg/mL; LOQ = 0.45 μg/mL); 
4Myricetin (y = 23287x – 581708, R2 = 0.9988, LOD = 0.23 μg/mL; LOQ = 0.78 μg/mL); 5Quercetin-3-O-glucoside (y = 34843x - 160173, R2 = 0.9998, LOD = 0.21 
μg/mL; LOQ = 0.71 μg/mL); 6Peonidin-3-O-glucoside (y = 151438x - 3E + 06, R2 = 0.9977, LOD = 0.12 μg/mL; LOQ = 0.39 μg/mL). 
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2.4.5. Statistical analysis 
All determinations and assays were carried out in triplicate, and 
results were expressed as the mean ± standard deviation (SD). Statistical 
analysis was performed by using the STATISTICA v.12 software (StatSoft 
Inc., 2014, OK, USA). Firstly, to meet the requirements for the perfor-
mance of analysis of variance (ANOVA) the normality of residuals and 
homoscedasticity were assessed by conducting the Saphiro-Wilk’s and 
Levene’s tests, respectively. Then, one-way ANOVA was carried out to 
evaluate statistical differences between treatments, followed by Tukey’s 
HSD post hoc test. Statistical differences with respect to positive controls 
were evaluated by Student’s t-test The significance level was adjusted at 
α = 0.05 in all cases. 
3. RESULTS AND DISCUSSION 
3.1. Identification and quantification of phenolic compounds 
The results from the analysis performed by HPLC-DAD-ESI/MSn on 
the hydroethanolic extracts of Bryophyllum cultured in vitro are pre-
sented in Table 1. A total of 18 flavonoids, grouped as non-anthocyanin 
and anthocyanin phenolic compounds, were tentatively identified by 
this chromatographic method: 1 flavanone (peak 1), 2 flavones (peaks 2 
and 15), 12 flavonols (peaks 3 to 14), and 3 anthocyanins (peaks 16 to 
18). 
The main non-anthocyanin phenolic compounds reported on the 
three Bryophyllum species were flavonol glycosides (peaks 3 to 14), 
mainly represented by myricetin glycosides (peaks 4 to 8). Peaks 4 to 8 
exhibit a DAD and an ion fragmentation pattern coherent with myricetin 
glycoside derivatives. All five compounds revealed a major MS2 ion at 
m/z 317, characteristic of an ionized myricetin. For peaks 4 and 5, the 
loss of an hexosyl (− 162 u) and deoxyhexosyl (− 146 u) moieties, was 
observed, being assigned as myricetin-3-O-glucoside (in comparison 
with commercial standard) and myricetin-O-deoxyhexoside, respec-
tively. Peaks 6 to 8revealed the same pseudo-molecular ion [M–H]− at 
m/z 595 and presented only one MS2 fragment, at m/z 317 (myricetin 
aglycone; pentosyl residue (− 132 u) and a deoxyhexosyl moiety (− 146 
u)), being tentatively identified as myricetin-O-pentosyl-deoxyhexoside 
derivatives (Ghouti et al., 2018; Ziani et al., 2018). 
Peaks 3, 11, and 14 presented a DAD spectrum and a MS2 frag-
mentation pattern coherent with kaempferol glycoside derivatives. Peak 
3([M–H]− at m/z 725) was tentatively identified as kaempferol-O- 
deoxyhexoside-pentoside-O-hexoside; the fragmentation pattern in MS2 
gave two ions, a minor one at m/z 563, suggesting the loss of a hexosyl 
unit ([(M–H) − 162]− ), and major at m/z 285, corresponding to 
kaempferol aglycone after the loss of both a pentosyl and a deoxy-
hexoside residue [(M–H)− 132 − 146]− . Similarly, peak 14 ([M-H]- at 
m/z 563) was tentatively identified as kaempferol-O-deoxyhexoside-O- 
pentoside. Peak 11([M–H]− at m/z 461) revealed one major ion frag-
ment at m/z285, resulting from the loss of a glucuronyl acid residue 
([M–H–176]− ) and therefore was tentatively identified as kaempferol-O- 
glucuronide (Barros et al., 2011; Geng et al., 2016). 
Moreover, peaks 9, 10 and 12 showed a DAD and MS2 fragment at m/ 
z 301, characteristic of quercetin glycoside derivatives. Peak 9 
([M–H]− at m/z 549) exhibited daughter peaks at m/z 505 and 463, 
which correspond to the loss of a malonyl moiety [(M–H)− 44 + 42]− , 
followed by the base peak at m/z 301 corresponding to quercetin agly-
cone, after the hexosyl moiety loss (− 162 u). This compound was 
tentatively assigned as quercetin-O-malonylhexoside. Peak 10 was 
positively identified as quercetin-3-O-glucoside ([M–H]− at m/z 463), in 
comparison with the commercial standard. Peak 12 was tentatively 
identified as quercetin-O-deoxyhexosyl-O-pentoside, revealing the loss 
of a pentosyl and a deoxyhexosyl residue [(M–H) − 132 − 146]− (Ghouti 
et al., 2018; Ziani et al., 2018). 
Finally, with respect to flavonol glycosides, peak 13 ([M-H]- at m/z 
507) was tentatively assigned to spinacetin-O-hexoside taking into ac-
count its fragmentation pattern (Boukhris et al., 2016). All these 
compounds (peaks 3 to 14) belong to the flavonol subclass, which 
constitutes one of the most abundant flavonoid subclasses previously 
described for the Bryophyllum subgenus (Fürer et al., 2013; Stefano-
wicz-Hajduk et al., 2020b, 2020a; Tatsimo et al., 2012). 
Besides flavonol glycosides, other flavonoid subclasses were also 
described in the Bryophyllum extracts, including flavones, such as api-
genin (peak 2) and acacetin (peak 15) glycosides, and one flavanone 
(peak 1; Table 1). Peak 2 was tentatively identified as apigenin-C- 
dihexoside, with a pseudo-molecular ion at m/z 593, and a base peak at 
m/z 473 [(M–H)− 120]− , a typical fragmentation of di-C-glycosyl fla-
vones (Tahir et al., 2012). The MSn fragments at m/z 353 [(M–H) − (120 
+ 120)]− and at m/z 383 [(M–H) − (90 + 120)]− indicated the presence 
of apigenin (mw 270) as aglycone and two hexosyl moieties (El Sayed 
et al., 2016; Geng et al., 2016). Peak 15([M–H]− at m/z 591) was 
tentatively identified as acacetin-O-rutinoside. The MS2 analysis gave 
two ions, a major one at m/z 283, characteristic of an ionized acacetin, 
which suggests the loss of a rutinosyl group ([(M–H)− 146 + 162]− ); and 
a minor one at m/z 269, suggesting the loss of a methyl group [(M–H)−
14]− , characteristic of the apigenin structure (Lin and Harnly, 2010; 
Parejo et al., 2004). Peak 1([M–H]− at m/z 449) presented a typical MS2 
fragment at m/z 287, indicating a deprotonated molecule 
[eriodictyol–H] and the loss of one hexosyl moiety [(M–H)–162]–, 
respectively, and was tentatively identified as eriodictyol-O-hexoside 
(Pereira et al., 2013; Vallverdú-Queralt et al., 2011). Other authors re-
ported acacetin glycosides in the leaves of B. pinnatum (Fürer et al., 
2013) together with other flavones (Muzitano et al., 2006; Nascimento 
et al., 2015), as already detected in B. tubiflorum (Huang et al., 2013a) 
and B. daigremontianum (Stefanowicz-Hajduk et al., 2020a). 
Concerning anthocyanins, only malvidin glycosides were identified 
in the leaf extracts of in vitro-cultured Bryophyllum spp. (peaks 16 to 18; 
Table 1). Peaks 16 to 18 were tentatively identified as glycosidic forms 
of anthocyanidins found in plants; the MS2 fragment at m/z 331 is the 
typical base peak of malvidin derivatives. Peak 16([M–H]− at m/z 655) 
presented a consecutive loss of two hexosyl moieties [(M–H)− 162 −
162]− and was tentatively identified as malvidin-O-dihexoside. Peak 17 
([M–H]− at m/z 493) exhibited a base peak at m/z 331, corresponding to 
the loss of an hexosyl moiety (− 162 u), being assigned as malvidin-3-O- 
glucoside. Whereas, peak 18 ([M–H]− at m/z 463) revealed the loss of a 
pentosyl residue [(M–H)− 132]− , being identified as malvidin-O-pento-
side (Flamini, 2013). These compounds are associated with flower 
pigmentation of other species belonging to the Kalanchoe genus, 
together with other anthocyanins, such as peonidin and delphinidin 
(Nielsen et al., 2005). However, they have also been produced in root 
cultures (Góraj-Koniarska et al., 2015). The presence of anthocyanins in 
the leaves of Bryophyllum spp. might be responsible for the dark, pig-
mented strands located in the abaxial leaf surface of these plants, as 
suggested by other authors (Casanova et al., 2020). This hypothesis is 
reinforced by the presence of idioblasts found in the leaf structure of 
B. daigremontianum and B. tubiflorum, considered cell reservoirs for 
phenolic compounds (Casanova et al., 2020; Chernetskyy et al., 2018). 
Regarding the quantification of phenolic compounds, culture media 
composition and species were two significant factors affecting the 
accumulation of the different compounds (Table 1). As a general rule, 
the macronutrient reduction on 1/2MS caused a significant positive 
effect (p < 0.05) on the accumulation of phenolic compounds, including 
both non-anthocyanins and anthocyanins in all species (Table 1), due to 
a potential induction of phenolic compound biosynthesis caused by 
nutritional stress. 
Myricetin glycosides were the non-anthocyanin flavonoids found in 
highest concentrations, with a maximum value of 5.62 mg g-1 in 
B. daigremontianum cultured on 1/2MS, corresponding to the compound 
myricetin-O-pentosyl deoxyhexoside (peak 6; Table 1). These results are 
in line with the previously reported contents for Bryophyllum spp. 
cultured in vitro, in which macronutrient reduction led to an increased 
accumulation of phenolic compounds, being B. daigremontianum the 
species showing the highest accumulation of flavonoids (García-Pérez 
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et al., 2020b). Such nutrient reduction can be seen as a form of abiotic 
stress, considered as nutritional stress, which results in the induction of 
secondary metabolite biosynthesis (García-Pérez et al., 2020b). As it was 
shown for low nitrogen, potassium, and phosphate concentrations 
(Blasco et al., 2018; Cramer et al., 2011), the phenylpropanoid biosyn-
thetic pathway was enhanced via the modulation of key biosynthetic 
genes, such as phenylalanine ammonia lyase (PAL) and chalcone syn-
thase (CHS) (Sharma et al., 2019). In the case of in vitro-cultured Bryo-
phyllum spp., ammonium was predicted to promote the accumulation of 
phenolic compounds, as a result of the application of artificial intelli-
gence tools (García-Pérez et al., 2020b), being also a critical factor on 
plant growth (García-Pérez et al., 2020d). This stress-induced over-
production of secondary metabolites is called elicitation, and was pre-
viously reported for Bryophyllum spp. (García-Pérez et al., 2019b). 
Similarly, in the specific case of anthocyanins, their concentrations 
significantly increased (p < 0.05) by nutritional stress in all species 
(peaks 16-18; Table 1). Although the highest values were found on B. ×
houghtonii cultured on 1/2MS, showing a concentration of 6.19 mg g-1 
for malvidin-O-hexoside (peak 17; Table 1), the most significant effect of 
nutrient stress was observed on B. tubiflorum, with a 54.4% increase 
(from 4.09 to 9.00 mg g-1 for anthocyanin phenolic compounds, 
Table 1). These findings reinforce the hypothesis that macronutrients 
present a species-dependent narrow range of efficacy, which should be 
optimized in order to meet specific requirements for every genotype 
(Castro et al., 2018; García-Pérez et al., 2020d). 
The highest values for total phenolics were presented by B. ×
houghtonii, 41.64 mg g-1 under nutritional stress (1/2MS; Table 1). 
However, the strongest effect of nutritional reduction was observed for 
B. tubiflorum, showing a 19.6% increase (Table 1). This species- 
dependent behavior for phenolic accumulation was previously re-
ported for Bryophyllum cultured in vitro (García-Pérez et al., 2020a, 
2020b), suggesting that even genetically close species show different 
requirements for several physiological features, as it was also noted for 
other physiological features, such as in vitro growth and organogenesis 
(García-Pérez et al., 2020d, 2020e). 
3.2. In vitro biological activities 
3.2.1. Antioxidant activity 
Table 2 shows the results for the in vitro antioxidant activity of 
Bryophyllum extracts through the two methods employed (TBARS and 
OxHLIA). The results from TBARS assay were given as IC50, which 
indicates the extract concentration required to prevent by 50% the 
malondialdehyde formation throughout the H+ donation to lipid radi-
cals. In parallel, the results for OxHLIA assay were also given as IC50, 
which indicates the extract concentration needed to protect the 50% of 
erythrocyte population. Hemolysis was induced by the free-radical 
initiator 2,2’-azobis(2-amidinopropane) dihydrochloride (AAPH) and 
antioxidant activity was measured at Δt = 60 min, in order to allow the 
performance of all compounds present in the extracts, which can show 
different action ranges along time (Lockowandt et al., 2019). In both 
cases, lower IC50 values correspond to higher antioxidant activity of 
plant extracts. 
As it can be seen in Table 2, the highest antioxidant activity was 
reported to extracts from plants cultured under nutritional stress 
(cultured on 1/2MS medium) in all species for both TBARS and OxHLIA 
assays, except for B. tubiflorum in OxHLIA. These findings correlate to 
the observed results for phenolic composition of Bryophyllum extracts, 
which suggest that phenolic compounds, such as myricetin and malvidin 
glycosides, are responsible for this antioxidant activity, as previously 
reported for both compounds (Barzegar, 2016; Huang et al., 2016). 
Specifically, the mechanism of action of these compounds has been 
associated to free-radical scavenging activity, due to their ability to 
donate H+ and/or e- with the aim of forming more stable radicals (Heim 
et al., 2002). 
According to the results for TBARS, the IC50 values for B. × houghtonii 
cultured on 1/2MS (27.7 μg mL-1) were only 5.2-fold higher than the 
positive control, 5.4 μg mL-1, represented by the artificial antioxidant 
Trolox, whereas the results for B. daigremontianum and B. tubiflorum 
were significantly higher, 45 μg mL-1 and 77 μg mL-1, respectively 
(Table 2). It is noteworthy that Trolox is a single, artificial molecule with 
enhanced antioxidant activity, whereas plant extracts contain a heter-
ogenous composition of phytoconstituents that may interact either 
positively or negatively, leading to different rates of antioxidant activity 
(Tsao and Deng, 2004). 
Similarly, in the case of OxHLIA, the same patterns were observed, 
being the extracts from B. × houghtonii cultured on 1/2MS the ones 
showing the lowest IC50 values, 79 μg mL-1. It supposes an increase of 
28.8% and 30.7% in the antioxidant activity, with respect to their 
counterparts for B. daigremontianum and B. tubiflorum, respectively 
(Table 2). Again, the positive control reached significantly higher values 
(19 μg mL-1). 
The results for both antioxidant assays are in accordance to the 
previous knowledge provided by in vitro-cultured Bryophyllum spp. A 
Table 2 
Antioxidant, cytotoxic, hepatotoxic and anti-inflammatory activity of Bryophyllum extracts.   
B. daigremontianum B. × houghtonii B. tubiflorum Positive controls  
MS 1/2MS MS 1/2MS MS 1/2MS  
Antioxidant activity (IC50, μg mL-1)1 Trolox 
TBARS 72 ± 2bA 45 ± 1aB 82 ± 5bB 27.7 ± 0.3aA 83 ± 2bB 77 ± 1aC 5.4 ± 0.3* 
OxHLIA Δt = 60 min 124 ± 3bB 111 ± 1aB 180 ± 4bC 79 ± 2aA 110 ± 4aA 114 ± 4aB 19 ± 1* 
Cytotoxic activity (GI50, μg mL-1)1 Ellipticine 
NCI-H460 
(lung cancer) 
15.0 ± 0.6aA 24.9 ± 1.2bC 15.4 ± 0.8bA 13.8 ± 1.1aA 20.2 ± 1.2bB 16.8 ± 1.5bB 0.9 ± 0.1* 
MCF-7 
(breast carcinoma) 
11.6 ± 0.7aA 19.7 ± 1.9bC 11.1 ± 0.3bA 9.6 ± 1.2aA 14.9 ± 0.3bB 13.4 ± 1.0aB 1.21 ± 0.03* 
HeLa 
(cervical carcinoma) 
15.2 ± 0.6aA 29.9 ± 1.6bB 15.2 ± 0.6bA 14.0 ± 0.2aA 17.1 ± 0.3aB 16.0 ± 1.3aA 1.0 ± 0.1* 
HepG2 
(hepatocellular carcinoma) 
16.5 ± 1.1aB 34.5 ± 4.1bB 13.1 ± 0.6aA 13.6 ± 1.0aA 15.30 ± 0.04bB 13.9 ± 0.5aA 1.1 ± 0.1* 
Hepatotoxic activity (GI50, μg mL-1)1 Ellipticine 
PLP2 
(liver primary culture) 
118.9 ± 3.1aB 146.2 ± 11.1bB 112.6 ± 2.9bB 101.4 ± 4.3aA 89.2 ± 6.9aA 99.29 ± 5.03bA 3.2 ± 0.7* 
Anti-inflammatory activity (IC50, μg mL-1)1 Dexamethasone 
RAW 264.7 26.5 ± 0.6aA 40.3 ± 2.9bC 26.3 ± 1.1aA 25.2 ± 1.7aA 31.3 ± 1.9aB 29.7 ± 0.9aB 16.0 ± 1.0* 
Statistical differences were assessed by one-way ANOVA, followed by Tukey’s HSD post hoc test (α = 0.05): lower-case letters indicate significant differences among 
treatments within the same species, whereas upper-case letters indicate significant differences among species within the same treatment. Asterisks (*) indicate sta-
tistical differences between positive controls and every treatment according to Student’s t-test (α = 0.05). 
1 Note: lower IC50 and GI50 values correspond to higher antioxidant activity. 
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reduction in the macronutrient concentration of the culture media 
caused a significant 2.5-fold increase in the antioxidant activity, deter-
mined by the 2,2-diphenyl-picrylhidrazyl (DPPH) method, which was 
more evident in the case of B. × houghtonii (García-Pérez et al., 2020a, 
2020b, 2019a). In fact, it was recently demonstrated that extracts from 
in vitro-cultured B. × houghtonii effectively prevent lipid oxidation on 
food models, such as omega-3 enriched fish oil-in-water emulsions 
(García-Pérez et al., 2020a). 
A number of phytochemical reports have highlighted the antioxidant 
potential of different Bryophyllum species grown ex vitro and found 
higher IC50 values than the species employed in this work for TBARS 
assay, i.e.: 134.56 μg mL-1 for B. pinnatum (Mohan et al., 2012). This 
suggests that the establishment of plant in vitro culture emerges as an 
efficient strategy to enhance the antioxidant potential of Bryophyllum 
spp., as demonstrated for B. daigremontianum, B. × houghtonii and 
B. tubiflorum. 
3.2.2. Cytotoxic and hepatotoxic activity 
The results obtained for the cytotoxic activity of hydroethanolic 
Bryophyllum extracts against four different human cancer cell lines are 
shown in Table 2. The values for cytotoxic activity were expressed as 
GI50, which indicates the extract concentration (in μg mL-1) required to 
inhibit cell growth by 50%. In all cell lines tested, the extracts belonging 
to B. × houghtonii cultured on 1/2MS showed the highest cytotoxic ac-
tivity, although no significant differences (p > 0.05) were found for 
HeLa and HepG2 between B. × houghtonii and B. tubiflorum (Table 2). In 
contrast, the extracts from B. daigremontianum showed the highest ac-
tivity for MS-grown plants (Table 2). This differential observation may 
indicate that, besides phenolic compounds, there are other families of 
secondary metabolites that contribute to the development of cytotoxic 
activity in this species, i.e.: bufadienolides. Bufadienolides are C-24 
steroidal compounds, widely distributed among Bryophyllum subgenus, 
that show a potent cytotoxic activity against a series of human cancer 
cell lines (García-Pérez et al., 2019, 2020c). However, the flavonoids 
present in Bryophyllum extracts, such as myricetin and malvidin, also 
present an associated cytotoxic activity, establishing a close relationship 
between plant phenolic content (Table 1) and cytotoxicity (Table 2), in 
agreement with previous results (Hyun and Chung, 2004; Semwal et al., 
2016). 
Regarding cancer cell lines, MCF-7 (breast carcinoma) was the most 
sensitive to Bryophyllum extracts, showing the lowest GI50 values for all 
species, mostly B. × houghtonii (9.6 μg mL-1; Table 2). The rest of cell 
lines tested, including NCI-H460 (lung cancer), HeLa (cervix carcinoma) 
and HepG2 (hepatocellular carcinoma) presented a similar sensitivity 
against B. × houghtonii cultured on 1/2MS, with GI50 values ranging 
13.6 – 14.0 μg mL-1. These results show the same patterns as reported in 
recent reports conducted on B. daigremontianum cultured ex vitro, in 
which the cytotoxicity against MCF-7 (43.6 μg mL-1) was significantly 
higher than against HeLa cell line (100 μg mL-1) (Stefanowicz-Hajduk 
et al., 2020a). Several authors demonstrated that kaempferol and myr-
icetin, found on Bryophyllum spp. hydroethanolic extracts, showed a 
potent cytotoxic effect against MCF-7 cell line, thus suggesting that both 
molecules may be the major responsible for such effects observed for this 
cell line (Jiao and Zhang, 2016; Srinivas Raghavan et al., 2015). Spe-
cifically, myricetin has been shown to exert a 7-fold higher cytotoxic 
activity against MCF-7 than the HeLa cell line (Semwal et al., 2016). In 
addition, the cytotoxic activity of Bryophyllum spp. is well-known for a 
series of different species, including B. daigremontianum, as described 
earlier, B. × houghtonii (Supratman et al., 2001) and B. tubiflorum (Hsieh 
et al., 2016). Nevertheless, to the best of authors’ knowledge, this is the 
first work applying in vitro culture methodology as a solution to improve 
the phytochemical potential of Bryophyllum spp., in terms of cytotoxic 
activity. 
Hepatotoxicity was assessed by the use of one non-tumor PLP2 
porcine liver cell culture and results are shown in Table 2. Ellipticine 
was selected as the positive control, as it occurred for cytotoxic activity: 
despite its efficacy as cytotoxic agent (0.9 – 1.2 μg mL-1) (Stiborová 
et al., 2011), ellipticine also caused the highest toxicity against porcine 
liver cell line PLP2 (3.2 μg mL-1; Table 2). In this sense, Bryophyllum 
extracts showed a markedly lower hepatotoxicity, being MS-grown 
B. tubiflorum the species whose the extracts caused the highest hepato-
toxicity, 89.2 μg mL-1, with 27.9-fold higher GI50 values than ellipticine 
(Table 2). This lower hepatotoxicity associated to Bryophyllum extracts 
may be explained in the basis of their hepatoprotective properties, as 
demonstrated in both in vitro and in vivo assays (Yadav and Dixit, 2003). 
3.2.3. Anti-inflammatory activity 
The results obtained for the anti-inflammatory activity of Bryo-
phyllum extracts are displayed in Table 2. Anti-inflammatory activity 
was assessed by IC50 values (μg mL-1), which represent the extract 
concentration required to inhibit by 50% the NO production by LPS- 
induced macrophages. Our results show that B. × houghtonii presented 
the highest anti-inflammatory activity regardless of the composition of 
culture media, ranging 25.2 – 26.3 μg mL-1 together with MS-cultured 
B. daigremontianum extracts, whereas B. tubiflorum extracts promoted a 
significantly lower activity (Table 2). However, in all cases, dexameth-
asone, used as positive control, showed a more potent anti-inflammatory 
activity than Bryophyllum extracts. These patterns in the results are 
likely related to those from cytotoxic activity (Table 2). This observation 
may suggest a crosstalk between inflammation and cancer proliferation 
signaling pathways, in which macrophages play a relevant role, as 
demonstrated in many epidemiological studies (Elinav et al., 2013; 
García-Pérez et al., 2019). Therefore, the present work provides enough 
evidence showing that Bryophyllum phytochemical potential is devel-
oped by a wide range of bioactivities. Both myricetin and malvidin, as 
the most relevant phenolic compounds identified in Bryophyllum spp., 
were found to exert a potent effect on the LPS-induced NO biosynthesis 
by macrophages, via the inhibition of nuclear factor-kappa B (NF-κB) 
(Bognar et al., 2013; Hämäläinen et al., 2007). Previous phytochemical 
studies have pointed at flavonoids from B. tubiflorum as 
anti-inflammatory agents, showing different rates of activity depending 
on the compounds, whose IC50 values range between 4.5 – 19.6 μg mL-1 
(Huang et al., 2013b). Furthermore, the ethanolic extracts from 
B. pinnatum maintained their anti-inflammatory activity when trans-
ferred to in vivo murine models (Tanko, 2012), thus suggesting a 
promising approach for their application from in vitro to in vivo 
conditions. 
3.2.4. Antimicrobial activity 
Table 3 includes the results for antimicrobial activity, for both 
antibacterial (expressed as MIC and MBC) and antifungal activities 
(expressed as MIC and MFC). Concerning the antibacterial activities, 
differential results were obtained depending on the genotype employed. 
Bacillus cereus was the strain showing the highest sensitivity against 
Bryophyllum extracts (MIC = 0.9 mg mL-1 for 1/2MS-cultured 
B. daigremontianum extracts), together with other Gram-positive 
strains, such as Listeria monocytogenes and Staphylococcus aureus in a 
lesser extent (MIC = 1.8 and 3.6 mg mL-1, respectively). On the other 
hand, Escherichia coli was the Gram-negative strain showing the highest 
sensitivity against Bryophyllum extracts (MIC = 1.8 mg mL-1 for 1/2MS- 
cultured B. daigremontianum extracts), whereas Enterobacter cloacae and 
Salmonella Typhimurium showed an increased resistance (MIC = 7.2 mg 
mL-1), both providing identical results (Table 3). The MBC values were 
in accordance with the results shown for MIC (Table 3). 
In the case of antifungal activities, differential results were also ob-
tained depending on the genotype employed. Our results reflected a 
differential efficiency towards fungal strains: Aspergillus ochraceus 
showed the greatest sensitivity against all the extracts, with MIC values 
ranging between 0.5 mg mL-1, for B. daigremontianum and B. tubiflorum, 
and 0.8 mg mL-1, for B. × houghtonii (Table 3). In addition, 
B. daigremontianum and B. × houghtonii also showed an enhanced anti-
fungal activity against Aspergillus fumigatus and Penicillium funiculosum 
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(MIC = 0.8 mg mL-1 in all cases). The MFC values are in accordance with 
the results shown for MIC (Table 3). In all cases, positive controls 
showed greater antimicrobial activity than Bryophyllum extracts, prob-
ably due to the existence of heterogenous compounds with complex 
interactions that modulate such bioactivity, as stated above. 
Myricetin, as the most prevalent non-anthocyanin flavonoid on 
Bryophyllum spp. aerial parts, has been shown to exert a potent antimi-
crobial activity. Specifically, this flavonol was found to exhibit a potent 
inhibition of both DNA and RNA polymerases in E. coli (Ong and Khoo, 
1997) and showed a moderate growth inhibition against S. aureus and 
digestive-related bacteria (Xu and Lee, 2001), being our results in line 
with the previous literature. Malvidin, as the most representative 
anthocyanin in Bryophyllum spp., has also been associated to antimi-
crobial activity, including both antibacterial and antifungal activities 
(Cisowska et al., 2011). Thus, it is suggested that the phenolic constit-
uents of Bryophyllum extracts are responsible for the inhibition of both 
bacterial and fungal growth. Previous works already reported that 
Bryophyllum extracts have a significant antimicrobial activity, as 
demonstrated by B. daigremontianum, showing a moderate activity 
against B. cereus, S. aureus, E. coli and A. niger (Anisimov et al., 2009; 
Nahar et al., 2008). The efficiency of Bryophyllum against enterobacteria 
shows a general pattern, showing an enhanced antibacterial activity, as 
demonstrated for B. mortagei and B. fedtschenkoi (Richwagen et al., 
2019). In parallel, other authors have outlined the efficiency of Bryo-
phyllum extracts against another relevant bacteria, such as Pseudomonas 
aeruginosa, as found for B. daigremontianum (Nahar et al., 2008) and 
B. pinnatum (Okwu and Nnamdi, 2011). 
4. CONCLUSIONS 
In this work, the establishment of plant in vitro culture was per-
formed as an effective strategy to enhance the phytochemical potential 
of three medicinal plant species belonging to the subgenus Bryophyllum. 
The identification and quantification of phenolic compounds showed 
that these species are a valuable source of flavonols and anthocyanins. 
Concerning the genotype, the species B. daigremontianum showed the 
highest rates of myricetin glycosides, whereas B. × houghtonii presented 
the highest rates of malvidin glycosides. In both cases, the use of culture 
media formulation with a reduced macronutrient concentration, as an 
approach to induce nutritional stress, led to the accumulation of such 
compounds through a phenomenon called elicitation. To provide insight 
into the phytochemical potential of in vitro-cultured Bryophyllum spp., 
different biological activities were analyzed. According to both antiox-
idant activity assays employed in this work, the extracts from B. ×
houghtonii cultured under nutritional stress, showed the highest rates of 
antioxidant activity. The same extracts showed the highest cytotoxic 
activity, with an enhanced effectiveness towards MCF-7 breast carci-
noma cell line. Moreover, the anti-inflammatory activity presented the 
same patterns as observed for antioxidant and cytotoxic activity, in 
which extracts from B. × houghtonii under nutritional stress exhibited 
the highest activity. The results displayed in this work suggest that the 
highest rates of antioxidant, cytotoxic and anti-inflammatory activities 
attributed to B. × houghtonii cultured under nutritional stress are caused 
by the accumulation of anthocyanins, specifically malvidin glycosides. 
In this way, thanks to their associated antioxidant, cytotoxic and anti- 
inflammatory bioactivities, these anthocyanin-rich extracts, are 
considered as promising candidates to promote an integrative effec-
tiveness against the cancer-related phenomena, as it is the case of 
oxidative stress, inflammation and malignant cell proliferation, closely 
related during the initiation of carcinogenic process. Finally, concerning 
antimicrobial activity, the extracts obtained from B. daigremontianum 
cultured under nutritional stress showed the highest activity against 
both Gram-positive bacteria, such as B. cereus and L. monocytogenes, and 
Gram-negative bacteria, including E. coli, together with some fungal 
Aspergillus and Penicillium species. Overall, this study shed light about 
the phytochemical potential of an unexplored plant subgenus, by 
providing evidence for considering in vitro-cultured Bryophyllum spp. as 
a valuable source of bioactive compounds to be applied in different bio- 
based industrial areas. 
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Table 3 
Antimicrobial activity of Bryophyllum extracts. Streptomycin and ampicillin were used as control for bacterial growth; ketoconazole and bifonazole for fungus growth. 
The results were given as minimum inhibitory concentration (MIC), minimum bactericidal concentration (MBC) and minimum fungicidal concentration (MFC; all in 
mg mL-1).   
B. daigremontianum B. × houghtonii B. tubiflorum Positive controls  
MS 1/2MS MS 1/2MS MS 1/2MS  
Antimicrobial activity Streptomycin Ampicillin  
MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC MIC MBC 
B. cereus 1.6 3.2 0.9 1.8 1.7 3.4 1.6 3.1 1.8 3.6 6.6 13.2 0.1 0.2 0.3 0.4 
S. aureus 6.4 12.8 3.6 7.2 13.6 >13.6 12.4 >12.4 3.6 7.2 6.6 13.2 0.04 0.1 0.3 0.5 
L. monocytogenes 6.4 12.8 1.8 3.6 6.8 13.6 6.2 12.4 3.6 7.2 6.6 13.2 0.2 0.3 0.4 0.5 
E. coli 3.2 6.4 1.8 3.6 6.8 13.6 6.2 12.4 3.6 7.2 6.6 13.2 0.2 0.3 0.4 0.5 
E. cloacae 3.2 6.4 7.2 >7.2 5.1 6.8 6.2 12.4 3.6 7.2 6.6 13.2 0.2 0.3 0.3 0.5 
S. Typhimurium 3.2 6.4 7.2 >7.2 5.1 6.8 6.2 12.4 3.6 7.2 6.6 13.2 0.2 0.3 0.8 1.2 
Antifungal activity Ketoconazole Bifonazole  
MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC MIC MFC 
A. fumigatus 0.8 1.6 0.5 0.9 0.9 1.7 0.8 1.6 0.9 1.8 1.7 1.3 0.3 0.5 0.2 0.2 
A. ochraceus 0.8 1.6 0.5 0.9 0.9 1.7 0.8 1.6 0.5 0.9 0.8 1.7 0.2 0.5 0.1 0.2 
A. niger 1.2 1.6 0.9 1.8 1.7 3.4 2.3 3.1 1.8 3.6 1.7 3.3 0.2 0.5 0.2 0.2 
P. funiculosum 0.8 1.6 0.9 1.8 1.7 3.4 0.8 1.6 0.9 1.8 1.7 3.3 0.2 0.5 0.2 0.3 
P. ochrochloron 1.6 3.2 0.9 1.8 1.7 3.4 2.3 3.1 1.8 3.6 3.3 6.6 2.5 3.5 0.2 0.3 
P. verrucosum 0.8 1.6 0.9 1.8 1.7 3.4 2.3 3.1 0.9 1.8 1.7 3.3 0.2 0.3 0.1 0.2  
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